← Back
$CMPX All transactions

Compass Therapeutics, Inc.

A

$ Value

$0

Shares

2,000,000

Price

$0

Filed

Jan 5

Insider

Name

Schuetz Thomas J.

Title

CEO

CIK

0001591464

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,000,000

Footnotes

Represents restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first vesting on January 2, 2027. | 250,000 of the shares represent unvested restricted stock units ("RSU") granted on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on February 8, 2024. 478,125 of the shares represent unvested restricted stock units ("RSU") granted on January 9, 2024. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 9, 2025. 250,000 of the shares represent unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027. | The options vest over 48 substantially equal monthly installments starting February 2, 2026.

Filing Info

Accession No.

0001171843-26-000060

Form Type

4

Issuer CIK

0001738021

Schuetz Thomas J.'s History

Date Ticker Type Value
2026-02-08 CMPX F $239K
2026-01-09 CMPX F $250K
2026-01-02 CMPX A $1.3M
2026-01-02 CMPX A $0
2025-11-16 CMPX F $213K
2025-05-27 CMPX $21K

Other Insiders at CMPX (90d)

Insider Bought Sold Last
Schuetz Thomas J.
CHIEF EXECUTIVE OFFICER
2026-02-08